Last reviewed · How we verify

NCT04250623

Dermatological Assessment of Photoallergy and Phototoxicity

Completed NA Last updated 16 June 2021
What this trial tests

NA trial testing Health care product (gel) in Sensitivity, Contact in 29 participants. Completed in 21 May 2021.

Timeline
12 April 2021
Primary endpoint
21 May 2021
21 May 2021

Quick facts

Lead sponsorHerbarium Laboratorio Botanico Ltda
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment29
Start date12 April 2021
Primary completion21 May 2021
Estimated completion21 May 2021
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Herbarium Laboratorio Botanico Ltda

Who can join

Adults 18 to 70, any sex, with Sensitivity, Contact. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a clinical study for health care product safety assessment. The research will be conducted with 40 subjects\*, aged 18 to 70 years. The product will be applied on the right and/or left participant back for 3 consecutive weeks. After 10 days, will have another application of the same product, which will be removed in 24 hours. Medical evaluation will be available throughout the study to assess possible adverse events. The objective of the study is to observe the effects of the application of the product on the skin and prove the absence of photoallergy and phototoxicity. \* 29 completed the trial

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Herbarium Laboratorio Botanico Ltda trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04250623.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing